货号 | PRD206-50 |
简介 | Supplied as ready-to-use 5 ug protein balls |
别名 | B cell stimulatory factor-2; B-cell differentiation factor; BSF-2; BSF2CTL differentiation factor; CDF; HGFHSFIFNB2Hybridoma growth factor; IFN-beta 2; IFN-beta-2; IL-6B-cell stimulatory factor 2; Interferon beta-2; interleukin 6 (interferon, beta 2); interleukin BSF-2; interleukin-6; MGI-2A | 全称 | Interleukin 6 |
反应种属 | Human |
来源 | E. coli-derived Pro29 - Met212 |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 3569 (Human); 16193 (Mouse); 24498 (Rat); 399500 (Porcine); 280826 (Bovine); 403985 (Canine); 100034196 (Equine); 493687 (Feline); 100008733 (Rabbit) |
内毒素水平 | <0.10 EU per 1 μg of the protein by the LAL method. |
生物活性 | Measured in a cell proliferation assay using T1165.85.2.1 mouse plasmacytoma cells. Nordan, R.P. et al. (1987) J. Immunol. 139:813. The ED50 for this effect is typically 0.2-0.8 ng/mL. |
背景 | IL-6 (Interleukin-6) is a pleiotropic cytokine that acts in the acute phase reaction, inflammation, hematopoiesis, bone metabolism, and cancer progression. It contributes to chronic inflammation in obesity, insulin resistance, inflammatory bowel disease, arthritis, sepsis, and atherosclerosis. IL-6 signals through a receptor complex of IL-6 R alpha and gp130. gp130 is also a component of the receptors for CLC, CNTF, CT-1, IL-11, IL-27, LIF, and OSM. Soluble forms of IL-6 R alpha are generated by both alternative splicing and proteolytic cleavage. In a mechanism known as trans-signaling, complexes of soluble IL-6 and IL-6 R alpha elicit responses from gp130-expressing cells that lack cell surface IL-6 R alpha. |
Accession # | Q75MH2 |
运输条件 | Blue Ice |
N-terminal Sequence Analysis | Pro29 |
预期分子量 | 20.3 kDa |
SDS-PAGE | 21 kDa, reducing conditions |
存放说明 | 4℃ |
纯度 | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain |
参考文献 |
|
1 μg/lane of ProDots® Recombinant Human IL-6 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized with silver staining, showing a single band at 21 and 20 kDa, respectively. | |
ProDots® Recombinant Human IL-6 stimulates cell proliferation of the T1165.85.2.1 mouse plasmacytoma cell line.The ED50 for this effect is typically 0.2-0.8 ng/mL. |